BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 20514399)

  • 1. Molecular study on copper-mediated tumor proteasome inhibition and cell death.
    Xiao Y; Chen DI; Zhang X; Cui Q; Fan Y; Bi C; Dou QP
    Int J Oncol; 2010 Jul; 37(1):81-87. PubMed ID: 20514399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organic copper complexes as a new class of proteasome inhibitors and apoptosis inducers in human cancer cells.
    Daniel KG; Gupta P; Harbach RH; Guida WC; Dou QP
    Biochem Pharmacol; 2004 Mar; 67(6):1139-51. PubMed ID: 15006550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hinokitiol copper complex inhibits proteasomal deubiquitination and induces paraptosis-like cell death in human cancer cells.
    Chen X; Zhang X; Chen J; Yang Q; Yang L; Xu D; Zhang P; Wang X; Liu J
    Eur J Pharmacol; 2017 Nov; 815():147-155. PubMed ID: 28887042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective anticancer copper(II)-mixed ligand complexes: targeting of ROS and proteasomes.
    Ng CH; Kong SM; Tiong YL; Maah MJ; Sukram N; Ahmad M; Khoo AS
    Metallomics; 2014 Apr; 6(4):892-906. PubMed ID: 24549332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper(II) ions affect the gating dynamics of the 20S proteasome: a molecular and in cell study.
    Santoro AM; Monaco I; Attanasio F; Lanza V; Pappalardo G; Tomasello MF; Cunsolo A; Rizzarelli E; De Luigi A; Salmona M; Milardi D
    Sci Rep; 2016 Sep; 6():33444. PubMed ID: 27633879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer activity and computational modeling of ternary copper (II) complexes with 3-indolecarboxylic acid and 1,10-phenanthroline.
    Zhang Z; Wang H; Wang Q; Yan M; Wang H; Bi C; Sun S; Fan Y
    Int J Oncol; 2016 Aug; 49(2):691-9. PubMed ID: 27278680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrrolidine dithiocarbamate-zinc(II) and -copper(II) complexes induce apoptosis in tumor cells by inhibiting the proteasomal activity.
    Milacic V; Chen D; Giovagnini L; Diez A; Fregona D; Dou QP
    Toxicol Appl Pharmacol; 2008 Aug; 231(1):24-33. PubMed ID: 18501397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 8-hydroxylquinoline analogs induce copper-dependent proteasome inhibition and cell death in human breast cancer cells.
    Milacic V; Jiao P; Zhang B; Yan B; Dou QP
    Int J Oncol; 2009 Dec; 35(6):1481-91. PubMed ID: 19885572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel copper complexes as potential proteasome inhibitors for cancer treatment (Review).
    Zhang Z; Wang H; Yan M; Wang H; Zhang C
    Mol Med Rep; 2017 Jan; 15(1):3-11. PubMed ID: 27959411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of tumor cell apoptosis by taurine Schiff base copper complex is associated with the inhibition of proteasomal activity.
    Zhang X; Bi C; Fan Y; Cui Q; Chen D; Xiao Y; Dou QP
    Int J Mol Med; 2008 Nov; 22(5):677-82. PubMed ID: 18949390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of prostate cancer cellular proteasome activity by a pyrrolidine dithiocarbamate-copper complex is associated with suppression of proliferation and induction of apoptosis.
    Chen D; Peng F; Cui QC; Daniel KG; Orlu S; Liu J; Dou QP
    Front Biosci; 2005 Sep; 10():2932-9. PubMed ID: 15970547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts.
    Chen D; Cui QC; Yang H; Barrea RA; Sarkar FH; Sheng S; Yan B; Reddy GP; Dou QP
    Cancer Res; 2007 Feb; 67(4):1636-44. PubMed ID: 17308104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,10-Phenanthroline promotes copper complexes into tumor cells and induces apoptosis by inhibiting the proteasome activity.
    Zhang Z; Bi C; Schmitt SM; Fan Y; Dong L; Zuo J; Dou QP
    J Biol Inorg Chem; 2012 Dec; 17(8):1257-67. PubMed ID: 23053530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A binuclear complex constituted by diethyldithiocarbamate and copper(I) functions as a proteasome activity inhibitor in pancreatic cancer cultures and xenografts.
    Han J; Liu L; Yue X; Chang J; Shi W; Hua Y
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):477-83. PubMed ID: 24060341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative activities of nickel(II) and zinc(II) complexes of asymmetric [NN'O] ligands as 26S proteasome inhibitors.
    Frezza M; Hindo SS; Tomco D; Allard MM; Cui QC; Heeg MJ; Chen D; Dou QP; Verani CN
    Inorg Chem; 2009 Jul; 48(13):5928-37. PubMed ID: 19496541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-glutamine Schiff base copper complex as a proteasome inhibitor and an apoptosis inducer in human cancer cells.
    Xiao Y; Bi C; Fan Y; Cui C; Zhang X; Dou QP
    Int J Oncol; 2008 Nov; 33(5):1073-9. PubMed ID: 18949371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schiff base Cu(II) complexes as inhibitors of proteasome in human cancer cells.
    Konarikova K; Frivaldska J; Gbelcova H; Sveda M; Ruml T; Janubova M; Zitnanova I
    Bratisl Lek Listy; 2019; 120(9):646-649. PubMed ID: 31475547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor cellular proteasome inhibition and growth suppression by 8-hydroxyquinoline and clioquinol requires their capabilities to bind copper and transport copper into cells.
    Zhai S; Yang L; Cui QC; Sun Y; Dou QP; Yan B
    J Biol Inorg Chem; 2010 Feb; 15(2):259-69. PubMed ID: 19809836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells.
    Daniel KG; Chen D; Orlu S; Cui QC; Miller FR; Dou QP
    Breast Cancer Res; 2005; 7(6):R897-908. PubMed ID: 16280039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper (II) complex of salicylate phenanthroline induces the apoptosis of colorectal cancer cells, including oxaliplatin‑resistant cells.
    Liu Z; Fan L; Niu D; Chen M; Zhang W; Liu Y; Xu J; Wang D
    Oncol Rep; 2023 Sep; 50(3):. PubMed ID: 37503758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.